Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -0.135% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) O=C(NC1CC1)C1CCN(C2CCN(C(=O)c3ccc4cccc(F)c4n3)CC2)CC1
(b) COc1ccc2oc(=O)c(C(=O)N3CCN(c4ccccc4C)CC3)cc2c1
Answer: b. COc1ccc2oc(=O)c(C(=O)N3CCN(c4ccccc4C)CC3)cc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc2oc(=O)c(C(=O)N3CCN(c4ccccc4C)CC3)cc2c1
COc1ccc2oc(=O)c(C(=O)N3CCN(c4ccccc4C)CC3)cc2c1
6-methoxy-3-[4-(2-methylphenyl)piperazine-1-carbonyl]chromen-2-one